CRP and COVID-19: Elevated levels of CRP and D-dimer in patients with COVID-19 are also associated with an increased risk of thrombosis (Dujardin et al., 2020), poor prognosis, acute kidney injury, venous thromboembolism, death, and progression to critical illness (Smilowitz et al., 2021).